Quercetin: the other half of the senolytic protocol, and a flavonoid with an absorption problem

Best known as half of a protocol rather than on its own. The pairing has a real mechanistic reason behind it, and quercetin taken alone is a different and much less studied proposition.

Why the pairing exists

Animal-only or theoretical Senescent cells resist apoptosis by upregulating survival pathways, and different cell types depend on different ones. That is the reason the senolytic screen that identified dasatinib also identified quercetin, and the reason the two are used together: dasatinib is more effective against senescent preadipocytes, quercetin against senescent endothelial cells and some others. Neither covers the range alone.

So the combination is not a supplement bolted onto a drug — it is what the protocol was designed as, and every human senolytic trial to date has used both. Quercetin on its own has not been tested as a senolytic in people, which makes taking it alone for that purpose an extrapolation from a pairing.

Established clinical use Separately from any of that, quercetin has a long history as an anti-inflammatory flavonoid: it inhibits NLRP3 inflammasome activation and stabilises mast cells, which is the basis for its use as a natural antihistamine. That use is at daily amounts rather than pulses and is a different intervention from the senolytic one.

Absorption is the recurring problem

Established clinical use Plain quercetin aglycone is poorly absorbed — low single-digit bioavailability — and is rapidly conjugated in the gut and liver, so plasma concentrations after an oral dose are a small fraction of what the cell studies used. That gap between the concentration that kills senescent cells in a dish and the concentration a capsule produces is the central uncertainty about the whole approach.

Phytosome and other enhanced formulations improve absorption substantially and cost more, which is what the app’s drawbacks list is pointing at. Taking it with a fat-containing meal helps. None of that resolves the underlying question of whether the achieved concentration is enough.

The interaction nobody expects from a supplement

Established clinical use Quercetin inhibits CYP3A4 and P-glycoprotein and affects several drug transporters, so it can raise blood levels of drugs cleared by those routes. It also chelates and reduces the absorption of quinolone antibiotics, and it has antiplatelet activity that matters alongside anticoagulants. At the gram-per-day amounts a senolytic pulse uses, this is a pharmacological exposure rather than a dietary one.

That is the practical thing to carry away: it belongs on the medication list you give a clinician even though it came from a shop, and a pulse taken while on prescription medication is a medication event rather than a supplement day.

Monitoring, per the app, is inflammatory markers before and after a pulse — a plausible proxy rather than a validated one, since nothing measures senescent cell clearance outside a research setting. The fisetin page covers the other flavonoid senolytic and the dose-scaling problem both share.

The dosing rows the app records

Off-label or community practice Reproduced from the app’s reference so you can see what it holds, not as a recommendation. Which row applies to a particular person, if any, is a clinical decision this page does not make — and rows describing supraphysiological or post-cycle use are filtered out before this table is built, so what you see here is a subset.

What the app monitors alongside it

The panel below is the app’s own monitoring note for Quercetin, verbatim. None of the analytes it names has a page here yet.

Drawbacks and risks the app records

From the app’s own entry, and the last item is the honest one: the human trials used the combination, not quercetin alone.

• Poor bioavailability without bioavailability enhancers
• High doses needed for senolytic effect
• May interact with antibiotics (quinolones) and blood thinners
• Quality varies between supplements
• Quercetin phytosome more expensive but better absorbed
• Full senolytic effects require dasatinib combination per trials

Questions people actually ask

Does quercetin work as a senolytic on its own?

That has not been tested in people. Every human senolytic trial used it paired with dasatinib, and the pairing exists because the two cover different senescent cell types. Taking it alone for that purpose is an extrapolation.

Which form should be taken?

Plain quercetin is poorly absorbed; phytosome and similar enhanced formulations absorb substantially better and cost more. Taking it with fat helps either way. Whether any of them reaches a senolytic concentration is the unresolved question.

Does it interact with medication?

Yes — it inhibits CYP3A4 and P-glycoprotein, reduces absorption of quinolone antibiotics, and has antiplatelet activity. At senolytic amounts that is a pharmacological exposure and belongs on the medication list you give a clinician.

Is the antihistamine use the same thing?

No. That is a daily anti-inflammatory and mast-cell-stabilising use at lower amounts, and it is a separate proposition from the intermittent high-dose senolytic protocol.

Where the load-bearing numbers come from

Named rather than linked. Publisher URLs move, and a citation that resolves to a 404 two years from now is worse than one you can search for by name — every entry below is findable from the title and year alone.